Connection

Evangelos Terpos to Osteoprotegerin

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Osteoprotegerin.
Evangelos Terpos
Connection Strength
0.302
Osteoprotegerin
  1. Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood Adv. 2018 11 13; 2(21):2837-2847.
    View in: PubMed
    Score: 0.193
  2. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood. 2003 Aug 01; 102(3):1064-9.
    View in: PubMed
    Score: 0.065
  3. Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization. J Bone Miner Metab. 2018 Jul; 36(4):399-409.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.